Left Ventricular Systolic Dysfunction: Clinical Trials

3 trials for Left Ventricular Systolic Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Left Ventricular Systolic Dysfunction: new trials by email Literature Review of Left Ventricular Systolic Dysfunction trials Research Report on Left Ventricular Systolic Dysfunction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ertugliflozin for Functional Mitral Regurgitation
Ertugliflozin, Placebo - Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction
Phase 3CompletedAsan Medical Center1282020-11-042025-01-06
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
Placebos, Dobutamine - Sepsis, Cardiomyopathies
Phase 3CompletedUniversity Hospital, Limoges1362020-09-202025-11-21
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
Linagliptin, Placebo - Diabetes Mellitus, Type 2, Left Ventricular Systolic Dysfunction
Phase 3CompletedHeart Care Foundation1882015-07-012021-05-25

Narrower conditions

Ventricular Dysfunction, Left (3)  ·  Cardiomyopathies (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Mitral Valve Insufficiency (1)  ·  Sepsis (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Ventricular Dysfunction (3)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Valve Diseases (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Dobutamine (1)  ·  Linagliptin (1)  ·  ertugliflozin (1)

Sponsors

Asan Medical Center (1)  ·  Heart Care Foundation (1)  ·  University Hospital, Limoges (1)

Countries

France (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Carlo B. Giorda, MD (1)

Results publications

PMID 33755143, PMID 38690659, PMID 40588393